Comparison of three rheumatoid arthritis disease activity scores in clinical routine

References

• Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology: preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727–35
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44–8
   PubMed Web of Science ®Google Scholar
• Van Gestel AM, Prevoo ML, van't Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria. Arthritis Rheum 1996; 39: 34–40
   PubMed Web of Science ®Google Scholar
• Furst DE, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Bijlsma JW, et al. Update consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 20 02). Ann Rheum Dis 2002; 61(Suppl 2)ii2–7
   PubMedGoogle Scholar
• Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 2003; 42: 244–57
   PubMed Web of Science ®Google Scholar
• Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005; 52: 2625–36
   PubMed Web of Science ®Google Scholar
• Aletaha D, Nell VP, Stamm T, Uffman M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005; 7: R796–806
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries DJ, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31; 1988: 315–24
   Google Scholar
• Department of Rheumatology, University Medical Centre Nijmegen, The Netherlands. DAS-score.nl: home of the DAS. Available from:, , www.das-score.nl.
   Google Scholar
• Paulus HE, Ramos B, Wong WK, Ahmed A, Bulpitt K, Park G, et al. Western Consortium of Practicing Rheumatologists. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or disease activity score in patients with early rheumatoid arthritis. J Rheumatol 1999; 26: 2324–31
   PubMedGoogle Scholar
• Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297–334
   Web of Science ®Google Scholar
• Bland JM, Altman DG. Statistics notes: Cronbach's alpha. Br Med J 1997; 314: 572
   PubMed Web of Science ®Google Scholar
• Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measure 1960; 20: 37–46
   Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159–174
   PubMed Web of Science ®Google Scholar
• Pinals RS, Masi AT, Larsen RA. Preliminary criteria for remission in rheumatoid arthritis. Arthritis Rheum 1981; 24: 1308–15
   PubMed Web of Science ®Google Scholar
• Leeb, BF, Andel, L, Leder, S, Leeb, BA, Rintelen, B. The patient's perspective and rheumatoid arthritis disease activity indexes. Rheumatology (Oxford). 2005;44:360–5. Erratum in: Rheumatology (Oxford) 2005;44:569.
   PubMed Web of Science ®Google Scholar
• Sokka T, Hetland ML, Makinen H, Kautiainen H, Horslev-Petersen K, Luukkainen RK, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008; 58: 2624–51
   Google Scholar
• Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-Saez I, Unnebrink K, Kary S, et al. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum 2008; 59: 32–41
   PubMed Web of Science ®Google Scholar
• Rintelen B, Sautner J, Andel I, Nothnagl T, Leeb BF. The SDAI disease activity categories revised. Ann Rheum Dis 2005; 64(Suppl III)188
   PubMedGoogle Scholar
• Makinen H, Kautiainen H, Hannonen P, Sokka T. Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?. Ann Rheum Dis 2005; 64: 1410–13
   PubMed Web of Science ®Google Scholar
• Mierau M, Schoels M, Gonda G, Fuchs J, Aletaha D, Smolen JS. Assessing remission in clinical practice. Rheumatology 2007; 46: 975–9
   PubMed Web of Science ®Google Scholar
• Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263–9
   PubMed Web of Science ®Google Scholar
• Pincus T, Amara I, Segurado OG, Bergman M, Koch GG. Relative efficiencies of physician/assessor global estimates and patient questionnaire measures are similar to or greater than joint counts to distinguish adalimumab from control treatments in rheumatoid arthritis clinical trials. J Rheumatol 2008; 35: 201–5
   PubMedGoogle Scholar
• Cohen SB, Strand V, Aguilar D, Ofmann JJ. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin 1 antagonist (anakinra) therapy. Rheumatology (Oxford) 2004; 43: 704–11
   PubMedGoogle Scholar
• Leeb BF, Andel I, Sautner J, Bogdan M, Maktari A, Nothnagl T, et al. Disease activity measurement of rheumatoid arthritis. Comparison of the SDAI and the DAS28 in daily routine. Arthritis Rheum 2005; 53: 56–60
   PubMedGoogle Scholar
• Leeb, BF. Should physicians manipulate their assessment tools? No, they shouldn't!. J Rheumatol 2006;33:2359–60; author reply 2360–1.
   PubMedGoogle Scholar
• Harth M, Pope J. The measure of our measures. Rheumatology (Oxford) 2004; 43: 1465–7
   PubMedGoogle Scholar
• Sokka T, Kautiainen H, Toloza S, Mäkinen H, Verstappen SM, Lund Hetland M, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007; 66: 1491–6
   PubMed Web of Science ®Google Scholar
• Leeb BF, Haindl PM, Maktari A, Nothnagl T, Rintelen B. Disease Activity Score-28 values differ considerably depending on patient's pain perception and sex. J Rheumatol 2007; 34: 2382–7
   PubMed Web of Science ®Google Scholar
• Rintelen B, Haindl PM, Maktari A, Nothnagl T, Hartl E, Leeb BF. SDAI/CDAI levels in rheumatoid arthritis patients are highly determined by patient's pain perception and gender. Scand J Rheumatol 2008; 29: 1–4
   Google Scholar